Currenc Group, Inc. (CURR)

USD 1.41

(-0.28%)

Gross Profit Summary of Currenc Group, Inc.

  • Currenc Group, Inc.'s latest annual gross profit in 2023 was 17.35 Million USD , up 419.81% from previous year.
  • Currenc Group, Inc.'s latest quarterly gross profit in 2024 Q2 was 229 Thousand USD , down -94.8% from previous quarter.
  • Currenc Group, Inc. reported a annual gross profit of 3.33 Million USD in annual gross profit 2022, down -23.8% from previous year.
  • Currenc Group, Inc. reported a annual gross profit of 4.38 Million USD in annual gross profit 2021, up 349.44% from previous year.
  • Currenc Group, Inc. reported a quarterly gross profit of 4.4 Million USD for 2024 Q1, up 209.04% from previous quarter.
  • Currenc Group, Inc. reported a quarterly gross profit of 694 Thousand USD for 2023 Q2, down -28.97% from previous quarter.

Annual Gross Profit Chart of Currenc Group, Inc. (2023 - 2014)

Historical Annual Gross Profit of Currenc Group, Inc. (2023 - 2014)

Year Gross Profit Gross Profit Growth
2023 17.35 Million USD 419.81%
2022 3.33 Million USD -23.8%
2021 4.38 Million USD 349.44%
2020 975 Thousand USD 148.72%
2019 392 Thousand USD 28.94%
2018 304.01 Thousand USD 135218.67%
2017 -225.00 USD 99.67%
2016 -69.16 Thousand USD -204.14%
2015 66.41 Thousand USD 42.19%
2014 46.71 Thousand USD 0.0%

Peer Gross Profit Comparison of Currenc Group, Inc.

Name Gross Profit Gross Profit Difference
Esperion Therapeutics, Inc. 73.06 Million USD 76.246%
Theratechnologies Inc. 62.12 Million USD 72.064%
Safety Shot Inc -74.45 Thousand USD 23410.508%
Cosmos Health Inc. 4.34 Million USD -299.035%
Cronos Group Inc. 6.99 Million USD -148.27%
Ironwood Pharmaceuticals, Inc. 441.16 Million USD 96.066%
Kala Pharmaceuticals, Inc. -303 Thousand USD 5828.153%
Organogenesis Holdings Inc. 309.79 Million USD 94.397%
Universe Pharmaceuticals INC 10.07 Million USD -72.222%
ProPhase Labs, Inc. 16.23 Million USD -6.88%
Sonoma Pharmaceuticals, Inc. 4.74 Million USD -265.781%
Dynavax Technologies Corporation 182.11 Million USD 90.47%
Radius Health, Inc. 307.71 Million USD 94.36%
China SXT Pharmaceuticals, Inc. 553.97 Thousand USD -3033.071%
Alvotech -69.42 Million USD 125.001%
Sunshine Biopharma, Inc. 8.33 Million USD -108.13%
Alpha Teknova, Inc. 10.29 Million USD -68.573%
Intra-Cellular Therapies, Inc. 430.62 Million USD 95.97%
SCYNEXIS, Inc. 124.51 Million USD 86.061%
Harrow Health, Inc. 90.55 Million USD 80.833%
Biofrontera Inc. 16.62 Million USD -4.386%
DURECT Corporation 6.83 Million USD -154.081%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 96.686%
ANI Pharmaceuticals, Inc. 305.3 Million USD 94.315%
OptiNose, Inc. 62.35 Million USD 72.165%
RedHill Biopharma Ltd. 3.05 Million USD -468.282%
Aquestive Therapeutics, Inc. 29.75 Million USD 41.663%
Cumberland Pharmaceuticals Inc. 33.48 Million USD 48.168%
SIGA Technologies, Inc. 122.09 Million USD 85.784%
Lifecore Biomedical, Inc. 41.85 Million USD 58.527%
Shineco, Inc. 882.16 Thousand USD -1867.46%
Phibro Animal Health Corporation 312.48 Million USD 94.446%
Procaps Group S.A. 239.56 Million USD 92.755%
TherapeuticsMD, Inc. 1.3 Million USD -1233.05%
Regencell Bioscience Holdings Limited -745.58 Thousand USD 2427.868%
Viatris Inc. 6.43 Billion USD 99.73%
Sunshine Biopharma, Inc. 8.33 Million USD -108.13%
Rockwell Medical, Inc. 8.7 Million USD -99.406%
Incannex Healthcare Limited 12 Thousand USD -144535.875%
Aytu BioPharma, Inc. 54.58 Million USD 68.204%
Tilray Brands, Inc. 223.35 Million USD 92.229%
Collegium Pharmaceutical, Inc. 326.16 Million USD 94.679%
PetIQ, Inc. 252.74 Million USD 93.133%
Silver Spike Investment Corp. 8.1 Million USD -114.207%
Neurocrine Biosciences, Inc. 1.84 Billion USD 99.061%
Journey Medical Corporation 52.52 Million USD 66.954%
Alimera Sciences, Inc. 61.17 Million USD 71.626%
Petros Pharmaceuticals, Inc. 4.19 Million USD -314.116%
Assertio Holdings, Inc. 125.04 Million USD 86.12%
Shuttle Pharmaceuticals Holdings, Inc. -6811.00 USD 254927.558%
Embecta Corp. 749.9 Million USD 97.686%
Cyclo Therapeutics, Inc. -2.41 Million USD 820.126%
Procaps Group, S.A. 239.56 Million USD 92.755%
PainReform Ltd. -15 Thousand USD 115808.7%
Avadel Pharmaceuticals plc 27.11 Million USD 35.995%
Hempacco Co., Inc. -1.21 Million USD 1527.524%
Talphera, Inc. -4.89 Million USD 454.572%
Pacira BioSciences, Inc. 490.3 Million USD 96.46%
Alvotech -69.42 Million USD 125.001%
Lantheus Holdings, Inc. 709.54 Million USD 97.554%
Kamada Ltd. 52.59 Million USD 66.999%
Indivior PLC 907 Million USD 98.086%
Evoke Pharma, Inc. 4.97 Million USD -248.608%
Flora Growth Corp. 17.73 Million USD 2.152%
Cyclo Therapeutics, Inc. -2.41 Million USD 820.126%
Evolus, Inc. 140.52 Million USD 87.649%
HUTCHMED (China) Limited 453.55 Million USD 96.173%
Amphastar Pharmaceuticals, Inc. 343.96 Million USD 94.954%
Akanda Corp. 111.44 Thousand USD -15473.316%